Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibition
Authors
Keywords
-
Journal
PROSTATE
Volume 75, Issue 13, Pages 1341-1353
Publisher
Wiley
Online
2015-05-13
DOI
10.1002/pros.23015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Species-specific homing mechanisms of human prostate cancer metastasis in tissue engineered bone
- (2014) Boris M. Holzapfel et al. BIOMATERIALS
- Recent advances in head and neck squamous cell carcinoma — A review
- (2014) Yaghoub Safdari et al. CLINICAL BIOCHEMISTRY
- Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer
- (2014) C. Liu et al. CLINICAL CANCER RESEARCH
- Upregulation of glucose metabolism by NF-κB2/p52 mediates enzalutamide resistance in castration-resistant prostate cancer cells
- (2014) Yuanyuan Cui et al. ENDOCRINE-RELATED CANCER
- Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
- (2014) Irfan A. Asangani et al. NATURE
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST)
- (2014) Yezi Zhu et al. PROSTATE
- Destruction of Full-Length Androgen Receptor by Wild-Type SPOP, but Not Prostate-Cancer-Associated Mutants
- (2014) Jian An et al. Cell Reports
- Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/EnzalutamideversusAnti-androgen Receptor ASC-J9® Lead to PromotionversusSuppression of Prostate Cancer Metastasis
- (2013) Tzu-Hua Lin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of ABCB1 Expression Overcomes Acquired Docetaxel Resistance in Prostate Cancer
- (2013) Y. Zhu et al. MOLECULAR CANCER THERAPEUTICS
- Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non-Small Cell Lung Cancer
- (2013) R. Li et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells
- (2013) Chengfei Liu et al. PROSTATE
- Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling
- (2013) T-H Lin et al. Cell Death & Disease
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional p53 determines docetaxel sensitivity in prostate cancer cells
- (2012) Chengfei Liu et al. PROSTATE
- Survivin-Mediated Cancer Cell Migration Through GRP78 and Epithelial-Mesenchymal Transition (EMT) Marker Expression in Mahlavu Cells
- (2011) Cheng-Jeng Tai et al. ANNALS OF SURGICAL ONCOLOGY
- Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells
- (2011) B. B. Knight et al. ENDOCRINE-RELATED CANCER
- Overexpression of survivin is correlated with increased invasion and metastasis of colorectal cancer
- (2011) Xiao-Yuan Chu et al. JOURNAL OF SURGICAL ONCOLOGY
- Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion
- (2011) Meng Sun et al. PROSTATE
- Skeletal Related Events, Bone Metastasis and Survival of Prostate Cancer: A Population Based Cohort Study in Denmark (1999 to 2007)
- (2010) Mette Nørgaard et al. JOURNAL OF UROLOGY
- The Anti-Helminthic Niclosamide Inhibits Wnt/Frizzled1 Signaling
- (2009) Minyong Chen et al. BIOCHEMISTRY
- The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
- (2009) Michael Hedvat et al. CANCER CELL
- Inflammation and Cancer: IL-6 and STAT3 Complete the Link
- (2009) Jacqueline Bromberg et al. CANCER CELL
- Interleukin-6 Regulates Androgen Synthesis in Prostate Cancer Cells
- (2009) J. Y. Chun et al. CLINICAL CANCER RESEARCH
- Stat3 Promotes Metastatic Progression of Prostate Cancer
- (2008) Junaid Abdulghani et al. AMERICAN JOURNAL OF PATHOLOGY
- Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?
- (2008) Sergei Grivennikov et al. CANCER CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started